drugset / Trial / NCT03247140
The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers Volunteers
Timeline
- Start
- 2017-06-10
- Primary completion
- 2017-08-07
- Completion
- 2017-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | JLP-1401 | Unknown | — | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |
| Subject | Telmisartan | Other / unclassified | 40 mg | — |